Effect of Lidocaine Phonophoresis Versus Pulsed Ultrasound on Myofascial Pain Syndrome in Athletic Children (PH)
Primary Purpose
Treatment Side Effects
Status
Completed
Phase
Phase 1
Locations
Egypt
Study Type
Interventional
Intervention
Lidocaine
pulsed ultrasound
especially designed physical therapy program
Sponsored by
About this trial
This is an interventional treatment trial for Treatment Side Effects focused on measuring myofascial pain syndrome, pain quality
Eligibility Criteria
Inclusion Criteria:
• Age range from 10 to 14 years.
- All children have regional neck pain complaint.
- Tenderness in cervical trigger points in the midpoint of the upper border of trapezius muscle, from grade II to grade IV according to tenderness grading scheme (Hubbard and Berkoff, 1993) (Appendix I ) ● The diagnosis of an active MTrP in the upper trapezius according to (Ardiçet al . , 2002 and Bruno, 2005)
Exclusion Criteria:
• Neurological disorders.
- Dermatological disorders.
- Acute trauma prior to the study.
- Fibromyalgia, systemic disease and drug allergy history were excluded from the study.
- Having myofascial trigger points injection.
- Chronic pain in both sides of the body.
Sites / Locations
- faculty of physical therapy,Cairo University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Experimental
Experimental
Arm Label
group A
group b
group c
Arm Description
received especially designed physical therapy program
received pulsed ultrasound in addition to physical therapy program
received lidocaine phonophoresis in addition to physical therapy program
Outcomes
Primary Outcome Measures
interleukin 6
measurement of interleukin 6 cncentration in blood plasma
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04185194
Brief Title
Effect of Lidocaine Phonophoresis Versus Pulsed Ultrasound on Myofascial Pain Syndrome in Athletic Children
Acronym
PH
Official Title
Effect of Lidocaine Phonophoresis Versus Pulsed Ultrasound on Myofascial Pain Syndrome in Athletic Children
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Completed
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
January 1, 2019 (Actual)
Study Completion Date
March 1, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
A topical anesthetic gel lidocaine has been widely used as a local anesthetic to reduce the pain and discomfort. It provides local analgesia by blocking the initiation and transmission of impulses. Lidocaine topical anesthetic gel allows the use of high concentrations of the anesthetic bases without concern about local irritation, uneven absorption or systemic toxicity (Argoff, 2000 ). So, the aim of this study is to compare between the effect of lidocaine phonophoresis and pulsed ultrasound in myofascial pain syndrome in swimmers children.
Detailed Description
Fourty five children (athletic swimmers) participated in this study, and were classified into three groups ; First control group A : this group consisted of fifteen children were receiving traditional physical therapy program. Second study group B: this group consisted of fifteen children were receiving pulsed ultrasound in addition to traditional physical therapy program as the same as in group A. Third study group C: this group consisted of fifteen children were receiving lidocaine phonophoresis in addition to traditional physical therapy program as the same as in group A. Treatment program in the three groups applied three times a week for three successive months. The study was done in the outpatient clinic of Ismailiy Sporting Club, Ismailia, Egypt.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Treatment Side Effects
Keywords
myofascial pain syndrome, pain quality
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Model Description
randomized control trial
Masking
Participant
Masking Description
sealed envelopes
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
group A
Arm Type
Active Comparator
Arm Description
received especially designed physical therapy program
Arm Title
group b
Arm Type
Experimental
Arm Description
received pulsed ultrasound in addition to physical therapy program
Arm Title
group c
Arm Type
Experimental
Arm Description
received lidocaine phonophoresis in addition to physical therapy program
Intervention Type
Drug
Intervention Name(s)
Lidocaine
Other Intervention Name(s)
lidocaine topical
Intervention Description
transmission of the drug molecules to the underlying muscles
Intervention Type
Device
Intervention Name(s)
pulsed ultrasound
Intervention Description
using thermogenic and cavitation effect of ultrasound to reduce tight muscles and relieve pain
Intervention Type
Other
Intervention Name(s)
especially designed physical therapy program
Intervention Description
by myofascial trigger point release, stretching and strengthening exercises of upper trapezius muscle and infrared radiation by tungsten lamp for upper trapezius
Primary Outcome Measure Information:
Title
interleukin 6
Description
measurement of interleukin 6 cncentration in blood plasma
Time Frame
three months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
• Age range from 10 to 14 years.
All children have regional neck pain complaint.
Tenderness in cervical trigger points in the midpoint of the upper border of trapezius muscle, from grade II to grade IV according to tenderness grading scheme (Hubbard and Berkoff, 1993) (Appendix I ) ● The diagnosis of an active MTrP in the upper trapezius according to (Ardiçet al . , 2002 and Bruno, 2005)
Exclusion Criteria:
• Neurological disorders.
Dermatological disorders.
Acute trauma prior to the study.
Fibromyalgia, systemic disease and drug allergy history were excluded from the study.
Having myofascial trigger points injection.
Chronic pain in both sides of the body.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Asser Sallam, PhD
Organizational Affiliation
Suez Canal University
Official's Role
Study Director
Facility Information:
Facility Name
faculty of physical therapy,Cairo University
City
Giza
ZIP/Postal Code
12612
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
results of the study design, abstract, conclusion
Learn more about this trial
Effect of Lidocaine Phonophoresis Versus Pulsed Ultrasound on Myofascial Pain Syndrome in Athletic Children
We'll reach out to this number within 24 hrs